首頁 > 市場調查報告書 > 製藥

感染疾病

市場調查報告書

商品編碼

1460170

抗菌藥物抗藥性監測市場規模 - 按解決方案（診斷套件、系統和軟體）、應用（公共衛生監測、實驗室監測、臨床診斷）、最終用途（醫院、診所）和預測，2024 - 2032 年

Antimicrobial Resistance Surveillance Market Size - By Solution (Diagnostic Kits, Systems, & Software), Application (Public Health Surveillance, Laboratory Surveillance, Clinical Diagnostics), End-use (Hospitals, Clinics) & Forecast, 2024 - 2032

出版日期: 2024年02月29日 | 出版商:

Global Market Insights Inc. | 英文 100 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

在醫療保健組織、研究機構和政府機構之間的合作努力的推動下，抗菌藥物抗藥性監測市場規模預計從 2024 年到 2032 年將以 5.8% 的CAGR擴大。

不斷增加的夥伴關係正在促進監測技術的創新，從而能夠開發用於檢測和追蹤抗藥性病原體的先進工具。例如，2023 年 6 月，加拿大公共衛生局國家微生物實驗室 (NML) 的幾位研究人員調查了加拿大抗菌素抗藥性的流行情況。認知到需要一個可以捕獲全國各地資料的網路，NML 創建了抗菌素抗藥性網路(AMRNet)，這是一個基於實驗室的監測系統，用於收集臨床和獸醫實驗室中AMR 測試的細菌和真菌樣本的資料。此類合作措施匯集資源、專業知識和資料，以增強監測能力，從而製定更有效的抗菌藥物抗藥性控制策略，從而擴大市場前景。

整個產業分為解決方案、應用、最終用途和區域。

在解決方案方面，診斷軟體領域的抗菌藥物抗藥性監測市場預計從 2024 年到 2032 年將成長 6.3%。用於抗菌藥物抗藥性監測的先進軟體解決方案提供即時監測、資料分析和趨勢識別，幫助醫療機構制定有效的決策和感染控制措施。它們還可以快速識別抗藥性病原體，以便及時採取干涉措施和治療策略。此外，人工智慧和機器學習演算法的整合提高了監控系統的準確性和效率，進一步促進了該細分市場的成長。

根據應用情況，公共衛生監測領域的抗菌藥物抗藥性監測產業在 2023 年產生了可觀的收入，預計 2024 年至 2032 年CAGR為6.1%。世界各地的公共衛生機構依靠先進的監測系統來監測和追蹤抗藥性的傳播抗菌素抗藥性。加強監測能夠及時採取干涉措施、制定政策和有針對性的干涉措施，以在更廣泛的範圍內對抗抗菌素抗藥性。隨著人們越來越關注防止抗藥性病原體的傳播和改善患者的治療結果，對強大的公共衛生監測解決方案的需求將會增加。

從地區來看，亞太地區抗菌藥物抗藥性監測產業預計在 2024 年至 2032 年期間CAGR為 6.3%。人口眾多且多樣化，加上醫療保健支出不斷增加，刺激了該地區對有效監測解決方案的需求。政府採取了多項旨在控制傳染病和改善醫療基礎設施的措施。此外，抗菌藥物抗藥性病原體的日益普及正在推動先進監測技術的採用，從而擴大區域產業前景。

產業生態系統分析
產業影響力
- 成長動力
  - 抗菌藥物抗藥性發生率上升
  - 傳染病流行率不斷上升
  - 提高認知和篩檢計劃
  - 診斷技術的進步
- 產業陷阱與挑戰
  - 與程序相關的高成本
  - 缺乏標準化協議
成長潛力分析
監管環境
技術景觀
波特的分析
PESTEL分析

第 4 章：競爭格局

介紹
公司市佔率分析
競爭定位矩陣
戰略展望矩陣

第 5 章：市場估計與預測：按解決方案，2018 年 - 2032 年

主要趨勢
診斷試劑盒
診斷系統
診斷軟體
服務

第 6 章：市場估計與預測：按應用分類，2018 年 - 2032 年

主要趨勢
公共衛生監測
實驗室監測
臨床診斷
其他應用

第 7 章：市場估計與預測：按最終用途，2018 - 2032 年

主要趨勢
醫院
診所
研究與學術機構
其他最終用戶

第 8 章：市場估計與預測：按地區分類，2018 年 - 2032 年

主要趨勢
北美洲
- 美國
- 加拿大
歐洲
- 德國
- 英國
- 法國
- 義大利
- 西班牙
- 歐洲其他地區
亞太地區
- 日本
- 中國
- 印度
- 澳洲
- 韓國
- 亞太地區其他地區
拉丁美洲
- 巴西
- 墨西哥
- 阿根廷
- 拉丁美洲其他地區
中東和非洲
- 沙烏地阿拉伯
- 南非
- 阿拉伯聯合大公國
- 中東和非洲其他地區

第 9 章：公司簡介

Abbott Laboratories
Accelerate Diagnostics, Inc.
Becton, Dickinson and Company (BD)
Biomereiux SA
Bruker Corporation
Himedia Laboratories Pvt. Ltd.
Opgen Inc.
Danaher Corporation
Luminex Corporation
Merck & Co., Inc.
Thermo Fisher Scientific Inc.

簡介目錄

Product Code: 8340

Antimicrobial Resistance Surveillance Market size is projected to expand at 5.8% CAGR from 2024 to 2032 driven by the collaborative efforts among healthcare organizations, research institutions, and government bodies.

Increasing partnerships are fostering innovations in surveillance technologies, enabling the development of advanced tools for detecting and tracking resistant pathogens. For instance, in June 2023, several researchers at the Public Health Agency of Canada's National Microbiology Laboratory (NML) investigated the prevalence of antimicrobial resistance in Canada. Recognizing the need for a network that could capture data from across the nation, the NML created the Antimicrobial Resistance Network, or AMRNet, a lab-based monitoring system to collect data from bacterial and fungal samples tested for AMR in clinical and veterinary labs. Such collaborative initiatives pool resources, expertise, and data to enhance surveillance capabilities, leading to more effective strategies for antimicrobial resistance control, thereby augmenting the market outlook.

The overall industry is segmented into solution, application, end-use, and region.

In terms of solution, the antimicrobial resistance surveillance market from the diagnostic software segment is anticipated to witness 6.3% growth rate from 2024-2032. Advanced software solutions for antimicrobial resistance surveillance offer real-time monitoring, data analysis, and trend identification, aiding healthcare facilities in effective decision-making and infection control measures. They also provide rapid identification of resistant pathogens for enabling timely interventions and treatment strategies. Moreover, the integration of AI and ML algorithms enhances the accuracy and efficiency of surveillance systems, further adding to the segment growth.

Based on application, the antimicrobial resistance surveillance industry from the public health surveillance segment generated considerable revenue in 2023 and is estimated to depict a 6.1% CAGR between 2024 and 2032. Public health agencies worldwide rely on advanced surveillance systems to monitor and track the spread of antimicrobial resistance. Enhanced surveillance enables timely interventions, policy developments, and targeted interventions to combat antimicrobial resistance on a broader scale. With the increasing focus on preventing the spread of resistant pathogens and improving patient outcomes, the demand for robust public health surveillance solutions will rise.

Regionally, the Asia Pacific antimicrobial resistance surveillance industry is set to exhibit 6.3% CAGR during 2024-2032. The large and diverse population coupled with the rising healthcare expenditure are fueling the demand for effective surveillance solutions in the region. There are several government initiatives aimed at controlling infectious diseases and improving healthcare infrastructure. Additionally, the increasing prevalence of antimicrobial-resistant pathogens is driving the adoption of advanced surveillance technologies, thereby augmenting the regional industry outlook.

Chapter 1 Methodology & Scope

1.1 Market scope & definition
1.2 Base estimates & calculations
1.3 Data collection
1.4 Forecast calculations
1.5 Data validation
1.6 Data sources
- 1.6.1 Primary
- 1.6.2 Secondary
  - 1.6.2.1 Paid sources
  - 1.6.2.2 Public sources

Chapter 2 Executive Summary

2.1 Industry 360-degree synopsis

Chapter 3 Industry Insights

3.1 Industry ecosystem analysis
3.2 Industry impact forces
- 3.2.1 Growth drivers
  - 3.2.1.1 Rising incidence of antimicrobial resistance
  - 3.2.1.2 Increasing prevalence of infectious diseases
  - 3.2.1.3 Rising awareness and screening programs
  - 3.2.1.4 Advancements in diagnostic technologies
- 3.2.2 Industry pitfalls & challenges
  - 3.2.2.1 High cost associated with the procedures
  - 3.2.2.2 Lack of standardized protocols
3.3 Growth potential analysis
3.4 Regulatory landscape
3.5 Technological landscape
3.6 Porter's analysis
- 3.6.1 Supplier power
- 3.6.2 Buyer power
- 3.6.3 Threat of new entrants
- 3.6.4 Threat of substitutes
- 3.6.5 Industry rivalry
3.7 PESTEL analysis

Chapter 4 Competitive Landscape, 2023

4.1 Introduction
4.2 Company market share analysis
4.3 Competitive positioning matrix
4.4 Strategy outlook matrix

Chapter 5 Market Estimates and Forecast, By Solution, 2018 - 2032 ($ Mn)

5.1 Key trends
5.2 Diagnostic kits
5.3 Diagnostic systems
5.4 Diagnostic software
5.5 Services

Chapter 6 Market Estimates and Forecast, By Application, 2018 - 2032 ($ Mn)

6.1 Key trends
6.2 Public health surveillance
6.3 Laboratory surveillance
6.4 Clinical diagnostics
6.5 Other applications

Chapter 7 Market Estimates and Forecast, By End-Use, 2018 - 2032 ($ Mn)

7.1 Key trends
7.2 Hospitals
7.3 Clinics
7.4 Research & academic institutes
7.5 Other end-users

Chapter 8 Market Estimates and Forecast, By Region, 2018 - 2032 ($ Mn)

8.1 Key trends
8.2 North America
- 8.2.1 U.S.
- 8.2.2 Canada
8.3 Europe
- 8.3.1 Germany
- 8.3.2 UK
- 8.3.3 France
- 8.3.4 Italy
- 8.3.5 Spain
- 8.3.6 Rest of Europe
8.4 Asia Pacific
- 8.4.1 Japan
- 8.4.2 China
- 8.4.3 India
- 8.4.4 Australia
- 8.4.5 South Korea
- 8.4.6 Rest of Asia Pacific
8.5 Latin America
- 8.5.1 Brazil
- 8.5.2 Mexico
- 8.5.3 Argentina
- 8.5.4 Rest of Latin America
8.6 Middle East and Africa
- 8.6.1 Saudi Arabia
- 8.6.2 South Africa
- 8.6.3 UAE
- 8.6.4 Rest of Middle East and Africa